FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
CNBC on MSN11d
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
In June, Eli Lilly released additional data from the studies showing that Zepbound helped resolve OSA in almost half ... The ...
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...
Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients
Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and ...
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.
FDA approves Zepbound for obstructive sleep apnea
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...
EconoTimes11d
Eli Lilly’s Zepbound Becomes FDA’s First Weight-Loss Drug Approved for Sleep Apnea Treatment
The FDA has approved Eli Lillys Zepbound as the first weight-loss drug to treat obstructive sleep apnea, reshaping care for ...
STAT11d
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
NBC Chicago12d
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
In June, Eli Lilly released additional data from the studies showing that Zepbound helped resolve ... to evaluate the severity of obstructive sleep apnea and the effectiveness of treatments ...
MedCity News9d
Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea
Sleep apnea ... drug therapy, an Eli Lilly drug initially developed as a treatment for metabolic conditions. The FDA late Friday approved Lilly’s tirzepatide, brand name Zepbound, for the ...